These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


627 related items for PubMed ID: 29530788

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Methylation decreases the Bin1 tumor suppressor in ESCC and restoration by decitabine inhibits the epithelial mesenchymal transition.
    Wang X, Wang J, Jia Y, Wang Y, Han X, Duan Y, Lv W, Ma M, Liu L.
    Oncotarget; 2017 Mar 21; 8(12):19661-19673. PubMed ID: 28152502
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C, Shan Z, Hong J, Yang L.
    Int J Oncol; 2017 Jul 21; 51(1):235-244. PubMed ID: 28534966
    [Abstract] [Full Text] [Related]

  • 4. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
    Ji YM, Zhou XF, Zhang J, Zheng X, Li SB, Wei ZQ, Liu T, Cheng DL, Liu P, Song K, Tan T, Zhu H, Guo JL.
    Oncotarget; 2016 Mar 22; 7(12):14188-98. PubMed ID: 26893358
    [Abstract] [Full Text] [Related]

  • 5. TIM-3 promotes the metastasis of esophageal squamous cell carcinoma by targeting epithelial-mesenchymal transition via the Akt/GSK-3β/Snail signaling pathway.
    Shan B, Man H, Liu J, Wang L, Zhu T, Ma M, Xv Z, Chen X, Yang X, Li P.
    Oncol Rep; 2016 Sep 22; 36(3):1551-61. PubMed ID: 27430162
    [Abstract] [Full Text] [Related]

  • 6. Upregulation of sine oculis homeobox homolog 3 is associated with proliferation, invasion, migration, as well as poor prognosis of esophageal cancer.
    Du J.
    Anticancer Drugs; 2019 Jul 22; 30(6):596-603. PubMed ID: 30672777
    [Abstract] [Full Text] [Related]

  • 7. FAM3B promotes progression of oesophageal carcinoma via regulating the AKT-MDM2-p53 signalling axis and the epithelial-mesenchymal transition.
    He SL, Wang WP, Yang YS, Li EM, Xu LY, Chen LQ.
    J Cell Mol Med; 2019 Feb 22; 23(2):1375-1385. PubMed ID: 30565387
    [Abstract] [Full Text] [Related]

  • 8. S100A4 regulates motility and invasiveness of human esophageal squamous cell carcinoma through modulating the AKT/Slug signal pathway.
    Zhang K, Zhang M, Zhao H, Yan B, Zhang D, Liang J.
    Dis Esophagus; 2012 Feb 22; 25(8):731-9. PubMed ID: 22458600
    [Abstract] [Full Text] [Related]

  • 9. Significance of PI3K/AKT signaling pathway in metastasis of esophageal squamous cell carcinoma and its potential as a target for anti-metastasis therapy.
    Li B, Xu WW, Lam AKY, Wang Y, Hu HF, Guan XY, Qin YR, Saremi N, Tsao SW, He QY, Cheung ALM.
    Oncotarget; 2017 Jun 13; 8(24):38755-38766. PubMed ID: 28418888
    [Abstract] [Full Text] [Related]

  • 10. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y, Yi J, Zhang K, Bai F, Feng B, Wang R, Chu X, Chen L, Song H.
    J Exp Clin Cancer Res; 2017 Nov 16; 36(1):161. PubMed ID: 29145896
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway.
    Li B, Tsao SW, Li YY, Wang X, Ling MT, Wong YC, He QY, Cheung AL.
    Int J Cancer; 2009 Dec 01; 125(11):2576-85. PubMed ID: 19551863
    [Abstract] [Full Text] [Related]

  • 13. N-myc downstream-regulated gene 2 (NDRG2) suppresses the epithelial-mesenchymal transition (EMT) in breast cancer cells via STAT3/Snail signaling.
    Kim MJ, Lim J, Yang Y, Lee MS, Lim JS.
    Cancer Lett; 2014 Nov 01; 354(1):33-42. PubMed ID: 25153349
    [Abstract] [Full Text] [Related]

  • 14. 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE2 pathway.
    Zhu P, Yu H, Zhou K, Bai Y, Qi R, Zhang S.
    J Exp Clin Cancer Res; 2020 Jun 16; 39(1):113. PubMed ID: 32546278
    [Abstract] [Full Text] [Related]

  • 15. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
    Wang Z, Qu L, Deng B, Sun X, Wu S, Liao J, Fan J, Peng Z.
    Sci Rep; 2016 Sep 15; 6():33205. PubMed ID: 27628214
    [Abstract] [Full Text] [Related]

  • 16. Metastasis suppressor protein 1 regulated by PTEN suppresses invasion, migration, and EMT of gastric carcinoma by inactivating PI3K/AKT signaling.
    Wang H, Zhao Y, Cao L, Zhang J, Wang Y, Xu M.
    J Cell Biochem; 2019 Mar 15; 120(3):3447-3454. PubMed ID: 30246429
    [Abstract] [Full Text] [Related]

  • 17. RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways.
    Lu H, Jiang T, Ren K, Li ZL, Ren J, Wu G, Han X.
    Cell Physiol Biochem; 2018 Mar 15; 49(1):217-225. PubMed ID: 30138923
    [Abstract] [Full Text] [Related]

  • 18. Msi2 plays a carcinogenic role in esophageal squamous cell carcinoma via regulation of the Wnt/β-catenin and Hedgehog signaling pathways.
    Li Z, Jin H, Mao G, Wu L, Guo Q.
    Exp Cell Res; 2017 Dec 01; 361(1):170-177. PubMed ID: 29054489
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-489 targets XIAP to inhibit the biological progression of ovarian cancer via regulating PI3K/Akt signaling pathway and epithelial-to-mesenchymal transition.
    Jiang HW, Li L, Jiang P, Wang YF.
    Eur Rev Med Pharmacol Sci; 2020 Apr 01; 24(8):4113-4122. PubMed ID: 32373947
    [Abstract] [Full Text] [Related]

  • 20. ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-κB/MMP-9 signaling pathway.
    Zhang GJ, Zhao J, Jiang ML, Zhang LC.
    Biochem Biophys Res Commun; 2018 Feb 05; 496(2):387-393. PubMed ID: 29326045
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 32.